Lucerna, Inc. is addressing the $9 billion early-stage drug discovery failure problem with an RNA-focused approach. Traditional protein-centric methods target only 0.05% of the human genome, whereas our technology unlocks access to over 70%—vastly expanding drug discovery opportunities. Our mission is to develop faster, cost-efficient tools that make disease-modifying RNAs both “visible” and “druggable,” increasing the chances of treating diseases with unmet medical needs.
Lucerna offers innovative RNA-focused research reagents powered by our proprietary fluorogenic RNA (Spinach™) technology. Our robust, user-friendly imaging solutions provide real-time RNA visualization in live cells—enabling seamless integration across microscopy, flow cytometry, and high-content imaging platforms. Further, our hit screening platforms deliver cellular drug activity insights in high-throughput format, reducing costs and shortening hit discovery and validation timelines. Designed specifically for RNA-focused drug discovery, Lucerna’s innovative products address critical gaps in early-stage drug discovery. With faster workflows and unmatched versatility, our solutions support every phase of the RNA life cycle, from cellular studies to high-throughput drug discovery. Whether for imaging, screening, or industrial applications, our products empower scientists with precision, speed, and innovation.
Company Details
- Employees
- 5
- Address
- Brooklyn, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://lucernatechnologies.com
- HQ
- Brooklyn
Lucerna, Inc. Questions
Lucerna, Inc.'s website is https://lucernatechnologies.com
Lucerna, Inc.'s LinkedIn profile is https://www.linkedin.com/company/lucerna-inc.
Lucerna, Inc. has
5 employees.
View email and phone details for 5
employees at Lucerna, Inc..
Lucerna, Inc.'s industry is
Biotechnology Research
Lucerna, Inc.'s top competitors are
Buckle Therapeutics Inc.,
Fesarius Therapeutics,
Vor Bio,
Phythera Therapeutics, Inc,
Breakout Labs,
Synvivo, Inc,
Bioharmony Therapeutics,
Xylome,
Sterling Bio Machines,
Terra Bioforge.
Lucerna, Inc.'s categories are Biotechnology Research
